S. 316-110
From dKosopedia
Categories: Stubs | Senate Bills
This article is a stub. You can help dKosopedia by expanding it.
| Senate Bill 316 (110th Congress) | |
|---|---|
| A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. | |
| Sponsor: | Sen Kohl, Herb |
| Committees: | Senate Judiciary |
Bill Text
Update Status
- S. 316-110 — A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
- March 7, 2007: Senate committee/subcommittee actions. Status: Committee on the Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights. Hearings held.
External Links
| External links for S. 316 (110th Congress) |
|---|
| S. 316 at DailyKos |
| S. 316 at Thomas |
| S. 316 at Billhop |
| S. 316 at GovTrack |
| S. 316 at OpenCongress |
Source: thomas.gov search
![[Main Page]](../../../../upload/banner-blue-135.jpg)